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Abstract: The aim of the study was the preparation of a liposome complex with 
encapsulated lead ions, which were electrochemically detected. In particular, experiments 
were focused on the potential of using an electrochemical method for the determination of 
free and liposome-encapsulated lead and determination of the encapsulation efficiency 
preventing the lead toxicity. Primarily, encapsulation of lead ions in liposomes and 
confirmation of successful encapsulation by electrochemical methods was done. Further, 
the reduction effect of the liposome matrix on the detected electrochemical signal was 
monitored. Besides encapsulation itself, comparison of toxicity of free lead ions and lead 
ions encapsulated in liposome was tested. The calculated IC50 values for evaluating the 
lead cytotoxicity showed significant differences between the lead enclosed in liposomes 
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(28 µM) and free lead ions (237 µM). From the cytotoxicity studies on the bacterial strain 
of S. aureus it was observed that the free lead ions are less toxic in comparison with lead 
encapsulated in liposomes. Liposomes appear to be a suitable carrier of various substances 
through the inner cavity. Due to the liposome structure the lead enclosed in the liposome is 
more easily accepted into the cell structure and the toxicity of the enclosed lead is higher in 
comparison to free lead ions. 
Keywords: lead; liposome; toxicity; differential pulse voltammetry; cyclic voltammetry; 
atomic absorption spectrometry; IC50; Staphylococcus aureus 
 
1. Introduction 
Lead is a heavy metal, toxic at extremely low doses and it has the acute and chronic effects on 
human health. It shows multi-system tissue toxicity, causing neurological, cardiovascular, renal, 
gastrointestinal, hematologic, reproductive, genotoxic and carcinogenic effects [1]. Thanks to the 
negative characteristics of lead, it is necessary to monitor its amount in the body [2–6]. Moreover, 
some complexing agents could enhance or lower toxicity of this metal, thus the effects of such 
complexes should be considered. Liposomes are among such complexing agents. They are spherical 
nanoshells composed of lipid bilayers that enclose an aqueous phase. They are easily produced and 
stable in solution for a long time with no significant changes in size or structure [7]. Due to their small 
and controllable size (from tens to thousands of nanometers) and the presence of internal cavities, 
liposomes are the most investigated organic nanoparticles [8]. The internal cavity can be used for 
transporting enzymes, proteins, DNA, drugs and other substances [9–11]. Highly biocompatible 
liposomes can be modified by antibodies, protein receptors or radioactive substances [7,12,13]. 
Voltammetric methods can be used for characterization of the electroactive compounds in  
liposome cavity [14,15]. This study is focused on the application of electrochemical method for the 
determination of free and liposome-encapsulated lead and determination of the encapsulation 
efficiency preventing lead toxicity. 
2. Results and Discussion 
The first and basic step of the experiment was encapsulation of lead ions into the liposome cavity. 
Lead was chosen as a model substance because metals often form part of an electrochemical label. 
Examples of such systems are so called quantum dots, which are nanocrystals most often composed of 
metal sulphides or tellurides [16]. Detailed sample preparation is described in the Experimental section 
and in Figure 1. The creation of this nanostructure was tested using electrochemical methods and 
atomic absorption spectrometry (AAS). Electrochemical techniques are one of the best methods for 
detecting metals due to their low cost, high sensitivity and potential portability [17–21]. Atomic 
absorption spectrometry was applied as a method for total lead determination. The verification of the 
encapsulation process was done by comparison of the amounts of lead determined by electrochemical 
methods and AAS. Because of the fact, that the electrochemical method is able to determine the lead 
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on the surface of liposomes (and free in the solution) and on the contrary, AAS determines the total 
amount of lead (inside and outside of liposomes),the obtained difference should be thus related to the 
encapsulated lead amount. 
Figure 1. Scheme of lead encapsulation into the liposome structure. (A) Phospholipids 
were dissolved in chloroform. (B) After evaporation of the solvent (C) A lipid film was 
obtained. (D) Lead solution was added to the phospholipids bilayer. Samples were 
homogenized for 10 min using ultrasound. (E) The homogenized mixtures were heated  
and shaken for 15 min at 60 °C at Thermomixer Comfort (Eppendorf, Hamburg, 
Germany). (F) Non-captured lead ions were removed from the solution by dialysis. 
 
2.1. Cyclic Voltammetry of Lead—Liposome Complex 
A comparison of the signal changes of lead encapsulated in liposomes and a lead standard measured 
by CV is shown in Figure 2. With the increasing scan rate the lead signal increased (Figure 2A,B).  
It is clear from the results shown in Figure 2C that the change of the lead peak potential is not 
expressly influenced by scan rate. Lead standard signals and signals of lead in the liposomes are 
compared in Figure 2D. Lead concentrations in both samples were 20 µM. However, the signals of 
lead in liposomes were lower than the signals of samples containing lead standard only. Therefore, one 
may suggest that the liposome matrix reduces the detection of lead in the samples. Analytical outputs 
in Figure 2D are the slopes of linear dependence for lead standard y = 11.883x, R
2
 = 0.95 and lead in 
liposomes y = 7.897x, R
2
 = 0.94, which indicates that the slope for lead in liposomes is lower. 
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Figure 2. (A) Cyclic voltammograms of lead standards with concentration of 20 µM.  
(B) Cyclic voltammograms of lead in the liposome with concentration of 20 µM.  
(C) Changing the position of the lead standard peak and peak of lead encapsulated in the 
liposome depending on the applied scan rate. (D) Linear dependence for the peak heights 
of the lead standard signals and lead encapsulated in liposome signals on the applied scan 
rate. Lead was determined by CV method using different scan rates (50–800 mV/s).  
0.2 M acetate buffer (pH = 5) was used as the supporting electrolyte. The characteristic 
peak for lead was at a potential of −0.4 V. 
 
2.2. Lead Encapsulation in Liposome 
Differential pulse voltammetry (DPV) was the second electrochemical method which was used for 
lead determination. The influence of the presence of liposomes (in measured lead solutions) on the 
obtained electrochemical signal was monitored (Figure 3A). It was seen that the lead peak height 
depended on the various lead concentrations (within the range from 1.25 to 20 µM) and compared to 
the signal intensity of free lead in the same concentration range. The resulting decrease in signal 
intensity is shown in Figure 3A. The average value of signal decrease is 61.8%. The obtained signals 
showed the change in peak potential too (Figure 3B). Peaks detected for free lead (lead nitrate standard 
solution) were located at −0.473 V, while the peaks related to the lead-liposome mixture were  
located approximately at −0.485 V. While the free lead determination peak potential was independent 
on the lead concentration, in the case of liposomes the peak potential was slightly dependent on the 
lead concentration (Figure 3B) - the growing lead concentration caused the potential shift to a more 
positive value. 
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Figure 3. (A) Percentage decrease of lead signal by DPV method caused by the presence 
of liposome. (B) Change of the potential location of lead peaks determined with/without 
the presence of liposome. Inset b1: real voltammograms of free lead ions. Inset b2: real 
voltammograms of lead ions with liposome. (C) Lead amount in liposome fraction (created 
by dialysis) dependent on the originally used amount of lead (for the preparation of  
lead-liposome complexes). (D) The dependence of encapsulation efficiency on the 
originally used lead concentration. 
 
For the investigation of liposome encapsulation efficiency the amount of lead in the liposomal 
fraction (created by dialysis) was monitored. Because lead is low molecular weight substance it is 
necessary to suggest that some part will be located on the surface of liposome structures. Therefore the 
amount of lead in the liposomal fraction was monitored by AAS to obtain maximum lead amount that 
could possibly be immobilized in this fraction (according to the original liposome concentration, see 
Experimental). The dependence of the amount of lead in the liposomal fraction related to the originally 
used amount of lead is presented in Figure 3C. It is obvious that the maximum amount of immobilized 
lead was about 170 µg. Because the difference between originally used lead amounts 300 and 400 g 
led to similar results, it should be assumed that the maximum amount of immobilized lead lies in the 
range from 152 to 170 µg. 
The calculation of liposome encapsulation efficiency was based on the difference in the lead 
determination by AAS and DPV, as was mentioned above. The encapsulation efficiency was 
calculated in the concentration range of lead from 0.1 to 5 mM. The percentage of encapsulation 
efficiency related to the lead concentration is shown in Figure 3D. The calculated percentage was 
determined as the difference in the concentrations (obtained from above mentioned methods) and 
Int. J. Environ. Res. Public Health 2013, 10 6692 
 
 
related to the originally used lead concentration. From the presented results it is obvious that the 
measured values of lead enclosed in liposomes were distinctly lower in comparison with the originally 
used lead concentrations. The efficiency of encapsulation decreased with increasing original lead 
concentration, as follows: y = −7.046x + 42.013, R
2
 = 0.97. This means that application of a lower 
original lead concentration led to a better result and, according to the previous paragraph, the 
application of an original lead concentration in the range from 0.1 to 2 mM is suitable. Since it was 
found that the application of lower original lead concentrations resulted in higher efficiency of the 
capture of lead ions in the liposomes, for sequent experiments µM concentrations of lead were chosen. 
Figure 4. Spectrophotometric analysis of growth of the S. aureus in the presence of 
different concentrations of lead ions. (A) Microscopy images of S. aureus cells: (e1) 
Micrographs of control S. aureus cells (and enlarge image). (e2) Micrographs of cells after 
application of lead ions (250 μM) (and enlarge image). (B) Growth curves of S. aureus 
treated with different concentrations of lead ions (5, 10, 20, 50, 100, 150, 200 and 250 μM) 
without liposome. (C) Spectrophotometric analysis of the growth of S. aureus bacterial 
culture treated with lead ions concentrations of 5, 10, 20, 50, 100, 150, 200 and 250 μM 
after 6 and 24 h. (D) Growth curves of S. aureus treated with different concentrations  
of lead ions (5, 10, 20, 50, 100, 150, 200 and 250 μM) enclosed in liposome.  
(E) Spectrophotometric analysis of the growth of S. aureus bacterial culture treated with 
lead ions concentrations of 5, 10, 20, 50, 100, 150, 200 and 250 μM after 6 and 24 h. 
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2.3. Toxicity Determination of Free Lead Ions and Lead Encapsulated in the Liposome 
It is common knowledge that heavy metal ions cause inhibition of microorganism (bacterial) 
growth, therefore they are often incorporated into different kinds of materials to ensure antimicrobial  
activity [22,23]. The growth curves method serves as a tool to evaluate antimicrobial activity, as the 
effect of heavy metal ions on bacterial strains such as Staphylococcus aureus in this experiment [24–26]. 
It is possible to calculate the inhibition concentration value (IC50) from these curves via statistical 
methods [27]. Eight different concentrations of lead ions (5, 10, 20, 50, 100, 150, 200 and 250 μM) 
free (Figure 4A,B) or encapsulated into liposome (Figure 4C,D) were added to the bacterial strain  
S. aureus in this experiment. 
The application of heavy metal ions to S. aureus cells led to significant morphological changes, 
observed in the cells in terms of cell shapes and the cell wall thicknesses. The difference between 
control and S. aureus cells after lead ion application is presented in Figure 4A. The cell wall was 
considerably thickened and the presence of so called cross walls (septal midline) was observed. These inner 
transverse walls are formed due to the developing resistance. Similar phenomenon is commonly observed 
in the case of methicillin-resistant strains of S. aureus commonly called MRSA strains [28–30]. 
The growth curves of S. aureus treated with both lead variants (free lead ions and lead ions 
encapsulated in liposomes) are presented in Figure 4B,D. The growth was the most rapid in the first six 
hours of measurement; therefore the growth rate of each variant was compared to S. aureus control. 
The same evaluation was done after 24 h. This time period was chosen to represent the long-term 
effect of lead on S. aureus. The growth curves show that the lead ions both enclosed in liposomes and 
free had antimicrobial activity and this growth inhibition was more significant with the increasing lead 
ions concentration. The inhibition effect of individual lead concentrations and forms (free and 
encapsulated) are presented in Figure 4C,E. The presented growth rate inhibition was calculated as the 
percentage of difference between the growth rate of the S. aureus control and the individually treated 
variants related to the S. aureus control. Figure 4C presents results related to the system with free lead 
ions for 6 and 24 h. Presented results show that the long-term effect of free ions is lower about 16% on 
average compared to the short-term effect. The maximum inhibition effect was achieved for the 
concentration of 250 µM for both time periods; after 6 h there was a 64% and for 24 h a 51% 
inhibition effect. More rapid increase of the inhibition effect was observed with the variants of lead in 
liposomes (Figure 4E) compared to the variants without liposomes. Application of liposome 
encapsulation caused a reduction of the differences between the short and long-term effects. This 
difference was reduced to 8% on average. Free lead ion application produced a maximal inhibition in 6 h 
of 64% The same inhibition efficiency was achieved using lead encapsulated in liposomes at a 
concentration 100 µM, which is 2.5 times lower. Similarly, application of 29 µM encapsulated lead 
concentration had the same effect in a 24 h time period as 250 µM in the case of free lead ions. From 
these results it is obvious that the effect of liposomes is more evident in the long-term evaluation. It is 
necessary to add the information about the maximum inhibition effect for encapsulated lead which 
occurs at 250 µM and was about 99% for 6 h and 96% for 24 h. 
The statistically calculated IC50 values for evaluating the lead cytotoxicity are summarized in  
Table 1. Presented values show significant differences between the lead enclosed in liposomes and free 
lead. The various IC50 values confirm one important. After 24 h the difference between the IC50 values 
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for free and encapsulated lead is so different that this suggestion could be considered as confirmed. 
Similar results are presented in another related works [31–35]. 
Table 1. Calculated values of IC50 (as micro molar concentration of lead) for various times 
of S. aureus incubation. 
Hours Free lead Encapsulated lead 
6 10.3 43.4 
12 57.9 31.9 
18 315.6 25.5 
24 236.9 28.0 
Another important obvious trend is visible in the free ion application where the inhibition effect 
fades with time. An opposite trend is visible in the case of liposome encapsulation. Here the inhibition 
effect grows with a maximum at 18 h (but the difference at 24 h is small). These two opposite trends 
confirm, in fact, the basic fact about lead encapsulation because various ways of lead transport into  
S. aureus cell had to be done. The shorter way of free lead ions and the longer way for the liposome 
transport into cells. Another important thing is more stable time effect of encapsulated lead compared 
to free ions. A more stable time effect is necessary to understand in concentration range, as there is a 
small concentration difference between the various IC50 values during the whole time period (24 h). 
3. Experimental Section 
3.1. Chemicals and Materials 
Cholesterol, 1,2-dioleoyl-sn-glycero-3-phospho-rac-(1-glycerol) sodium salt, chloroform, Pb(NO3)2 
and water (for liposome preparation) of ACS purity quality were purchased from Sigma-Aldrich  
(St. Louis, MO, USA). Hydrogenated phosphatidylcholine from soybeans was a gift from Lipoid 
GMBH (Ludwigshafen, Germany). To pipette volumes down to micro- and nanolitres, pipettes were 
purchased from Eppendorf Research (Eppendorf, Hamburg, Germany). The water (for bacterial 
cultivation) was prepared using Aqual 25 reverse osmosis equipment (Brno, Czech Republic). The 
water was further purified by using a MiliQ Direct QUV apparatus equipped with the UV lamp (Aqua 
Osmotic, Tisnov, Czech Republic). The resistance was 18 MΩ. The pH was measured using a WTW 
inoLab pH meter (Weilheim, Germany). 
3.2. Preparation of Liposome 
Liposomes were prepared by modification of a published method [36]. Cholesterol (100 mg),  
1,2-dioleoyl-sn-glycero-3-phospho-rac-(1-glycerol) sodium salt (100 mg) and phosphatidylcholine 
(100 mg) were dissolved in chloroform (4.5 mL). A lipid film was obtained by rotary evaporation of 
solvent and residual chloroform was blown off with nitrogen. 
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3.3. Preparation of Liposome Filled with Lead 
Solutions containing 0, 0.5, 1, 2.5 and 5 mg of lead (in the form of lead nitrate) were added to 
liposomes (20 mg). Samples were homogenized with an Ultra-Turrax T8 (IKA Werke GMBH, 
Staufen, Germany) for 10 min. The homogenized mixtures were then heated and shaken for 15 min at 
60 °C at Thermomixer Comfort (Eppendorf). The samples were then washed several times with water 
on Amicon 3k (Millipore, Billerica, MA, USA). Final volume of samples was 1 mL. 
3.4. Electrochemical Determination 
3.4.1. Differential Pulse Voltammetry (DPV) 
Measurement of lead by DPV were performed with a 746 VA Trace analyser connected to a 695 
Autosampler (Metrohm, Zofingen, Switzerland), using a standard cell with three electrodes. For data 
processing the VA Database 2.2 software provided by Metrohm CH was employed. The parameters of 
the measurement were as follows: initial potential of −1.2 V, end potential 0.15 V, deposition potential 
−1.2 V, deposition 480 s, deoxygenating with argon 60 s. Dosage was 25 µL of the sample to 1,975 µL 
of acetate buffer pH = 5. 
3.4.2. Cyclic Voltammetry (CV) 
Determination of lead by CV were performed with a 797 VA Computrace instrument connected to a 
813 Compact Autosampler (Metrohm), using a standard cell with three electrodes. For data processing 
the 797 VA Computrace software by Metrohm CH was employed. The parameters of the measurement 
were as follows: initial potential of −1.2 V, first vertex potential 0.15 V, second vertex potential −1.2 V, 
sweep rate 50–800 mV/s, deposition potential −1.2 V, deposition 480 s, deoxygenation with argon 60 s. 
Before the measurement 25 µL of the sample was added to the 1,975 µL of 0.2 M acetate buffer pH = 5. 
3.5. Atomic Absorption Spectrometry (AAS) 
Determination of lead was carried out on an 240FS Agilent Technologies atomic absorption 
spectrometer (Agilent Technologies, Santa Clara, CA, USA) with flame atomization. The lead hollow 
cathode lamp (Agilent) was operated at the current of 10 mA. Lead was measured at the wavelength of 
217.0 nm with spectral bandwidth of 1.0 nm. The mixture of air and acetylene was used for flame 
atomization. Deuterium background correction was used and the signal was measured in integration 
mode for 2 s. 
3.6. Toxicity Determination of Free Lead Ions and Lead Encapsulated in the Liposome 
3.6.1. Cultivation of Staphylococcus aureus 
Staphylococcus aureus (NCTC 8511) was obtained from the Czech Collection of Microorganisms, 
Faculty of Science, Masaryk University, Brno, Czech Republic. Strains were stored as a spore 
suspension in 20% (v/v) glycerol at −20 °C. Prior to use in this study, the strains were thawed and the 
glycerol was removed by washing with distilled water. The composition of cultivation medium was as 
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follows: 10 g tryptone, 5 g yeast extract and 5 g NaCl/L MilliQ water (Duchefa Biochemie, Haarlem, 
The Netherlands).The pH of the cultivation medium was adjusted at 7.4 before sterilization. Sterilization 
of media was carried out at 121°C for 30 min in a Tuttnauer 2450EL sterilizer (Tuttauer, Breda, The 
Netherlands). The prepared cultivation media were inoculated with bacterial culture in 25 mL 
Erlenmeyer flasks. After inoculation, bacterial cultures were cultivated for 24 h on a shaker at 600 rpm 
and 37 °C. Bacterial culture cultivated under these conditions [37,38] was diluted by cultivation 
medium to OD600 = 0.1 and used in the following experiments. 
3.6.2. Growth Curves 
The procedure for the evaluation of the antimicrobial effect of the tested compounds involved 
measuring the absorbance using a Multiskan EX apparatus (Thermo Fisher Scientific, Waltham, MA, 
USA) and subsequent analysis in the form of growth curves [39,40]. The 24 h grown culture of S. 
aureus was diluted with LB medium (10 g tryptone, 5 g yeast extract, 5 g NaCl/L deionised water) 
using a Specord 210 spectrophotometer (Analytik Jena, Jena, Germany) at wavelength of 600 nm to 
absorbance 0.1. In the microplate S. aureus culture was mixed with various concentrations of lead in or 
without liposomes in different concentrations or S. aureus alone as a control for measurements. The 
concentrations of lead were 5, 10, 20, 50, 100, 150, 200 and 250 μM. Total volume in the microplate 
wells was 300 µL. Measurements were carried out at time 0, and every 30 min for 24 h at 37 °C at the 
wavelength of 620 nm. The values achieved were individually analysed in graphic form as growth 
curves for each group. 
3.6.3. Statistical Evaluation 
The software STATISTICA (data analysis software system), version 10.0 (StatSoft, Tulsa, OK, 
USA) was used for data processing. Half-maximal concentrations (IC50) were calculated from 
logarithmic regression of sigmoideal dose-response curves. A general regression model was used to 
analyse differences between the combinations of compounds. To reveal differences between cell lines, 
Turkey’s post hoc test within homogenous groups was employed. Unless noted otherwise, p < 0.05 
was considered significant. 
3.6.4. Cell Microscopy 
An inverted system microscope Olympus IX 71 (Tokyo, Japan) was used for imaging the cells. The 
cells in cultivation medium were pipetted (5 μL) onto a microscope slide and covered by a cover slip. 
The sample was placed cover slip down and the immersion oil was used. The objective (PlanFLN; 
Mag. 100×; NA 1.3; F.N. 26.5) and the magnification lens 1.6 were used; the total magnification was 
1,600×. The images were captured by an Olympus DP73 camera and processed by the Stream Basic 
1.7 Software. The image resolution was 4,800 × 3,600 pixels. The parameters were as follows: 
exposure time: 32 ms and ISO 200. 
  




Liposomes appear to be a suitable carrier of various substances due to their inner cavity. This ability 
makes liposomes among the most researched organic nanoparticles. The lead encapsulation into the 
liposome structure and the influence of the liposome matrix on the electrochemical detection of lead 
was confirmed. Lead encapsulated in the liposomes is more easily accessible to the cells of S. aureus 
and its toxicity in comparison with free lead ions is higher. In addition, we have demonstrated that 
electrochemical methods could be very suitable tools for the determination of electroactive compounds 
enclosed in liposomes. 
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